Once-daily inhaled corticosteroids for the treatment of asthma
- 1 January 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 10 (1) , 15-21
Abstract
Inhaled corticosteroids (ICS) are the mainstay of asthma therapy. Although compliance to this type of medication is often suboptimal and once-daily dosing can help to improve adherence to the treatment, the clinical implications of such a mode of administration should be determined. This review summarizes the recent studies on comparative efficacy of once-versus twice-daily administration of ICS, in light of previous reports. Although twice-daily administration of ICS is often better to optimize asthma parameters, in many patients, asthma can be sufficiently controlled by a once-daily regimen of most ICS. An increased frequency of dosing seems preferable if asthma becomes uncontrolled or is severe, although this requires further study. A therapeutic trial should, however, be done to ensure that asthma control is adequate. Comparative long-term effects of such a strategy on inflammatory and remodeling parameters remain to be determined, as does the proportion of patients who can adequately control their asthma with once-daily administration of the various ICS available.Keywords
This publication has 70 references indexed in Scilit:
- Budesonide Turbuhaler delivered once daily improves health-related quality of life and maintains improvements with a stepped-down dose in adults with mild to moderate asthmaAnnals of Allergy, Asthma & Immunology, 2003
- Efficacy and safety of fluticasone propionate 250 μg administered once daily in patients with persistent asthma treated with or without inhaled corticosteroidsAnnals of Allergy, Asthma & Immunology, 2002
- Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroidsAnnals of Allergy, Asthma & Immunology, 2001
- Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhalerAnnals of Allergy, Asthma & Immunology, 2001
- Efficacy and safety of dry powder fluticasone propionate in children with persistent asthmaAnnals of Allergy, Asthma & Immunology, 2000
- Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthmaJournal of Allergy and Clinical Immunology, 2000
- Once-Daily Inhaled Corticosteroids in Mild to Moderate AsthmaDrugs, 1999
- Adverse effects of inhaled budesonide (800 μg) on growth and collagen turnover in children with asthma: A double-blind comparison of once-daily versus twice-daily administrationThe Journal of Pediatrics, 1998
- Nonadherence in Asthmatic Patients: Is there a Solution to the Problem ?Annals of Allergy, Asthma & Immunology, 1997
- Compliance and Outcomes in Patients with AsthmaDrugs, 1996